Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/34945Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Liew, David F L | - |
| dc.contributor.author | Owen, Claire E | - |
| dc.date | 2024 | - |
| dc.date.accessioned | 2024-01-30T23:22:47Z | - |
| dc.date.available | 2024-01-30T23:22:47Z | - |
| dc.date.issued | 2024-01-18 | - |
| dc.identifier.citation | Rheumatology (Oxford, England) 2024-01-18 | en_US |
| dc.identifier.issn | 1462-0332 | - |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/34945 | - |
| dc.language.iso | eng | - |
| dc.title | Treat-to-target in polymyalgia rheumatica and giant cell arteritis: an impending, multi-faceted challenge. | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | Rheumatology (Oxford, England) | en_US |
| dc.identifier.affiliation | Rheumatology | en_US |
| dc.identifier.affiliation | Department of Medicine, University of Melbourne, Melbourne, Australia. | en_US |
| dc.identifier.doi | 10.1093/rheumatology/keae031 | en_US |
| dc.type.content | Text | en_US |
| dc.identifier.orcid | 0000-0001-8451-8883 | en_US |
| dc.identifier.pubmedid | 38243712 | - |
| item.grantfulltext | none | - |
| item.openairetype | Journal Article | - |
| item.languageiso639-1 | en | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.cerifentitytype | Publications | - |
| crisitem.author.dept | Rheumatology | - |
| crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
| crisitem.author.dept | Rheumatology | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.